期刊文献+

陡脉冲治疗卵巢癌中组织因子的变化

Steep Pulse Changes the Expression of Tissue Factor in Ovarian Tumor
下载PDF
导出
摘要 电脉冲因其微创,靶向性强,无明显禁忌而逐渐成为肿瘤治疗研究的热点。其对肿瘤治疗的有效性研究已取得一系列肯定的结果,但其治疗机制仍旧没有得到完全的研究证实。为明确陡脉冲对肿瘤的治疗机制,本实验采用能量可控陡脉冲(Energy controllable steep pulse,ECSP)治疗荷瘤裸鼠,检测既是凝血系统重要启动因子、又是肿瘤浸润和转移指标——组织因子(Tissue factor,TF)在ECSP治疗前后的变化,分析ECSP,肿瘤凝血状态及肿瘤浸润、转移之间的相互作用,浅析ECSP对肿瘤的治疗机理。实验中将裸鼠卵巢癌皮下移植瘤完全随机分为治疗组和未治疗组,ECSP对治疗组作用后,光镜从形态学观察血栓形成,免疫组织化学SP法、RT-PCR对TF进行定位和定量检测。结果显示,ECSP作用后肿瘤血栓明显形成,TF在肿瘤治疗组表达明显降低。结果表明,ECSP促血栓形成,消耗TF,改变肿瘤组织高凝状态;同时TF在卵巢癌组织表达减少,提示ECSP与卵巢癌的侵袭和转移受抑制有关。 As a micro-wound and target-aimed technology without special limitation, Electric Pulses have been widely researched in tumor treatment and the effects have been demonstrated by a series of experiments, yet the mechanism has not been explained clearly, In this experiment, energy controllable steep pulse (ECSP) was used to treat nude mice bearing human ovarian tumor,and the result was compared with that of the control group. The expression of an important coagulant factor-tissue factor (TF) was analyzed, as TF was also a tumor indicator of invasion and metastasis, the result may indicate the relationship among ECSP, thrombosis and tumor invasion. In this study, to shed light on the mechanism of tumor treatment in electrical fields, nude mice bearing ovarian tumors were randomly divided into the treated group and the untreated group. We treated the former group and took out the tumor instantly. The thrombosis and necrosis of ovarian tumor were observed under microscope. The expression of TF was analyzed by SP irnmunohistochemistry and RT-PCR. Lower level of TF expression was noticed in the tumor tissue treated by ECSP, and more apparent thrombosis was also seen in this group. The results make it clear that ECSP can accelerate thrombosis and consume coagulant factors such as TF, and that low expression of TF in tumor tissue can cut out the signal paths of tumor invasion. So it is suggested that ECSP may restrain tumor invasion and metastasis by modulating thrombosis.
出处 《生物医学工程学杂志》 CAS CSCD 北大核心 2008年第2期402-406,共5页 Journal of Biomedical Engineering
基金 国家自然科学基金资助项目(30371619) 重庆大学研究生教育创新基金资助项目(2004A031)
关键词 卵巢癌 能量可控陡脉冲 组织因子 血栓形成 Ovarian tumor Energy controllable steep pulse(ECSP) Tissue factor(TF) Thrombosis
  • 相关文献

参考文献4

二级参考文献23

  • 1温汉平,王小宁.肿瘤细胞体外药敏试验MTT分析法[J].中华肿瘤杂志,1993,15(6):470-471. 被引量:63
  • 2张锦珠,孔克健,鲁崎唔,董仁杰.脉冲电场对人红细胞膜结构影响的冷冻断裂研究[J].实验生物学报,1994,27(2):183-191. 被引量:3
  • 3朱帆三,陈柏好,林家瑞,谢则平.R波同步电脉冲治疗癌症的实验研究[J].中国生物医学工程学报,1995,14(4):299-305. 被引量:2
  • 4Shalaby F, Rossant J, Yamaguchi T P, et al. Failure of blood-island formation and vasculogenesis in Flk-1 deficient mice. Nature, 1995, 376(6535): 62~66
  • 5Sato T N, Tozawa Y, Deursh U, et al. Distinct roles of the receptor tyrosine kinase Tie-1 and Tie-2 in blood vessel formation. Nature, 1995, 376(6535):70~74
  • 6Dumont D J, Gradwohl G, Fong G H, et al. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev, 1994, 8(16):1897~1909
  • 7Lohr F, Lo D Y, Zaharoff D A, et al. Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation. Cancer Res, 2001, 61(8):3281~3284
  • 8Duda D G, Sunamura M, Lozonschi L, et al. Direct in vitro evidence and in vivo analysis of the antiangiogenesis effects of interleukin 12. Cancer Res, 2000, 60(4):1111~1116
  • 9Paul D, Qazilbash M H, Song K, et al. Construction of a recombinant adeno-associated virus (rAAV) vector expressing murine interleukin-12 (IL-12). Cancer Gene Ther, 2000, 7(2):308~315
  • 10Caruso M, Pham-Nguyen K, Kwong Y L, et al. Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma. Proc Natl Acad Sci USA, 1996, 93(21):11302~11306

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部